There are a number of elements in Bill C-393. As I think I said last Thursday, this is very intricate: A goes to B to go to C, etc., so you have to follow the thread through the fabric, so to speak. But yes, I think that's a fair comment.
Some of the anti-abuse provisions that were in the Patent Act are removed by the proposals in Bill C-393. If you remove those anti-diversion or anti-abuse provisions, then you are in a very difficult situation if you try to enforce the limitations of the waiver agreement and the scheme for exporting drugs under compulsory licence.
Thank you, Mr. Chair.